Table 1.
Immunophenotypic analysis
| Marker | hADSCs Phenotype | Description | Control % | Rapid % | P value |
|---|---|---|---|---|---|
| CD31 | − | Endothelial cell marker | 0.66 | 0.83 | 0.60 |
| CD34 | − | Hematopoietic/endothelial marker | 2.24 | 2.79 | 0.68 |
| CD44 | + | Chondrogenic potency marker | 99.86 | 99.82 | 0.57 |
| CD45 | − | Leukocyte cell marker | 1.05 | 0.89 | 0.53 |
| CD49c | + | Chondrogenic potency marker | 95.43 | 95.52 | 0.98 |
| CD73 | + | Extracellular adenosine production | 98.61 | 98.34 | 0.79 |
| CD90 | + | Cell–cell–matrix interactions | 97.78 | 97.86 | 0.95 |
| CD146 | − | Cell migration and angiogenesis | 2.28 | 1.92 | 0.80 |
The table shows the summary of the immunophenotype performed using flow cytometry on hADSCs isolated under control and rapid procedures. The most representative patient’s analysis is reported here (n = 3)